Figure 3From: Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma Overall survival rate (A) and tumor progression rate (B) of patients in TACE+RFA group and TACE alone group. Back to article page